← Browse by Condition
Medical Condition

pancreatitis

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for pancreatitis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pancreatitis Clinical Trials

How many clinical trials are currently recruiting for pancreatitis?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for pancreatitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pancreatitis?
pancreatitis research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pancreatitis clinical trial?
Eligibility criteria for pancreatitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Air Force Military Medical University, China 1 trial
Icahn School of Medicine at Mount Sinai 1 trial
Medical University of Warsaw 1 trial
Copenhagen University Hospital, Hvidovre 1 trial

Recruiting Clinical Trials

NCT07071441
Recruiting
Indomethacin vs Diclofenac for Preventing PEP
Enrollment
4,050 pts
Location
China
Sponsor
Air Force Military Medical Uni...
View Trial →
NCT02775461
Recruiting
Pancreas Registry and High Risk Registry
Enrollment
1,368 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
View Trial →
NCT07024199 Phase 4
Recruiting
Comparison of the Effectiveness of Paracetamol With Ibuprofen or Paracetamol With Metamizole in Treating Pain in Acute Pancreatitis in Children
Enrollment
78 pts
Location
Poland
Sponsor
Medical University of Warsaw
View Trial →
NCT03853447
Recruiting
Fibro-inflammatory Progression From Acute to Chronic Pancreatitis
Enrollment
150 pts
Location
Denmark
Sponsor
Copenhagen University Hospital...
View Trial →

Related Conditions

chronic pancreatitis (2) ercp (1) non steroidal anti inflammatory nsaid (1) indomethacin (1) diclofenac (1) pancreas cancer (1) pancreatic cyst (1) family history of pancreas cancer (1) genetic mutations (1) pancreatitis acute (1) pain acute (1) pancreatic disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology